Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 02, 2014
 
Register | Sign in
Home Page>Products
  Product News
Selvita Licenses Cresset’s Forge and Spark
Thursday, September 04, 2014
Computational tools for SAR analysis and ligand-based design.

Major Pharma Chooses CompacT SelecT Automated Cell Culture System
Thursday, September 04, 2014
To generate consistent, high quality cell plates for transport assays.

FEI Releases New Helios NanoLab G3 DualBeam
Thursday, September 04, 2014
Next generation DualBeam extends Helios performance leadership while enhancing usability with a new user interface and workflow-specific configurations.

FEI Announces Teneo VS for 3D Volume Imaging of Cells and Tissues
Thursday, September 04, 2014
The Teneo VS delivers excellent resolution over large volumes to allow life scientists to explore the structure and interactions of cells and tissues down to the nanometer scale.

The New Metrohm Meter(s) – Every Inch Metrohm!
Thursday, September 04, 2014
Metrohm presents the 912 Conductometer, the 913 pH Meter and the 914 pH/Conductometer, a new generation of meters for pH and conductivity measurement. The new meters are every inch «Metrohm» – robust, reliable, and remarkably simple to use.

Thermo Scientific Teams with NRLs on New European Regulation
Wednesday, September 03, 2014
Allowing GC-MS/MS to confirm dioxins in feed and food.

Abcam Introduces Exclusive Range of Highly Validated Antibody Conjugates
Wednesday, September 03, 2014
Offering reliable and specific research tools for multi-color experiments.

Videojet Improves Total Cost of Ownership with New Continuous Ink Jet Printers
Wednesday, September 03, 2014
New printers with Long Life Core™ technology extend time between planned wear parts replacement.

GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Tuesday, September 02, 2014
Delivering high quality gDNA from a single cell.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 10528
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv